This competitive renewal proposes to continue our investigation of allosteric enhancers (AEs) of the A1 adenosine receptor (A^R). These compounds bind to an allosteric site on the receptor to increase the affinity of adenosine to the orthosteric site on the A^R. We have identified new and improved aminothiophene AEs and we have discovered a new chemical class of more potent and effective aminothiazole AEs. We also have discovered that some disulfides and H2O2 have AE-like effects on the AiAR and the A^R. To learn more about the molecular mechanisms of AE action we investigated receptor mutants and chimera. We have developed a novel system to """"""""score"""""""" enhancer activity based on the ability of these compounds to prevent rapid dissociation of an agonist radioligand, 125I-ABA, from the A^R in response to GTPyS. We propose newstudies to achieve three specific aims.
Aim 1 is to synthesize new enhancer structures in two chemical classes and to characterize them based on radioligand binding to receptors and guanine nucleotide exchange from G proteins.
This aim i s guided by conformational molecular field analysis (CoMFA) of existing structures and the use of new synthetic techniques.
Aim 2 is to efficiently evaluate enhancer function in intact cells and to evaluate selected compounds for activity in modulating adenosine A1 receptor function in brain slices and stimulation of angiogenesis.
Aim 3 will investigate the role and disulfide bond formation in AE and H2O2 action through analysis of thiol alkylating agents, epitope- tagged receptors, site-directed mutagenesis and protein sequencing. We will also investigate the possibility the H2O2 is a physiological regulator of A^R signaling. We hypothesize that cysteines in the extracellular loops of the AiAR participate in disulfide cross linking reactions. AEs are significant therapeutic candidates that may reduce chronic pain or promote site-specific angiogenesis. Moreover, our investigation of the role of thiols/disulfides in enhancer and H2O2 action may reveal important new information about general mechanisms of GPCR G protein coupling and trafficking.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL056111-13
Application #
7568820
Study Section
Hypertension and Microcirculation Study Section (HM)
Program Officer
Schwartz, Lisa
Project Start
1996-04-20
Project End
2009-11-25
Budget Start
2009-01-01
Budget End
2009-11-25
Support Year
13
Fiscal Year
2009
Total Cost
$340,946
Indirect Cost
Name
University of Virginia
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
065391526
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Kennedy, Dylan P; McRobb, Fiona M; Leonhardt, Susan A et al. (2014) The second extracellular loop of the adenosine A1 receptor mediates activity of allosteric enhancers. Mol Pharmacol 85:301-9
Linden, Joel; Cekic, Caglar (2012) Regulation of lymphocyte function by adenosine. Arterioscler Thromb Vasc Biol 32:2097-103
Linden, Joel (2011) Regulation of leukocyte function by adenosine receptors. Adv Pharmacol 61:95-114
Alam, Mohammad S; Kurtz, Courtney C; Rowlett, Robert M et al. (2009) CD73 is expressed by human regulatory T helper cells and suppresses proinflammatory cytokine production and Helicobacter felis-induced gastritis in mice. J Infect Dis 199:494-504
Wilson, Jeffrey M; Ross, William G; Agbai, Oma N et al. (2009) The A2B adenosine receptor impairs the maturation and immunogenicity of dendritic cells. J Immunol 182:4616-23
Aurelio, Luigi; Valant, Celine; Figler, Heidi et al. (2009) 3- and 6-Substituted 2-amino-4,5,6,7-tetrahydrothieno[2,3-c]pyridines as A1 adenosine receptor allosteric modulators and antagonists. Bioorg Med Chem 17:7353-61
Locke, Landon W; Chordia, Mahendra D; Zhang, Yi et al. (2009) A novel neutrophil-specific PET imaging agent: cFLFLFK-PEG-64Cu. J Nucl Med 50:790-7
Ferguson, Gemma N; Valant, Celine; Horne, James et al. (2008) 2-aminothienopyridazines as novel adenosine A1 receptor allosteric modulators and antagonists. J Med Chem 51:6165-72
Aurelio, Luigi; Figler, Heidi; Flynn, Bernard L et al. (2008) 5-Substituted 2-aminothiophenes as A1 adenosine receptor allosteric enhancers. Bioorg Med Chem 16:1319-27
Nikolakopoulos, George; Figler, Heidi; Linden, Joel et al. (2006) 2-Aminothiophene-3-carboxylates and carboxamides as adenosine A1 receptor allosteric enhancers. Bioorg Med Chem 14:2358-65

Showing the most recent 10 out of 16 publications